Does CBD Help Sleep? What the Evidence Actually Shows

What CBD Does in the Brain That Relates to Sleep

CBD does not sedate you the way a benzodiazepine or zolpidem does. Instead, it acts on at least three receptor pathways that influence sleep architecture: it modulates CB1 cannabinoid receptors in the basal ganglia, binds 5-HT1A serotonin receptors (which reduce anxiety and may promote slow-wave sleep), and antagonizes GPR55 receptors associated with wakefulness [1]. Lower anxiety translates into shorter sleep-onset latency for people whose insomnia is driven by a racing mind.

Animal studies show that CBD at 10-40 mg/kg increases total sleep time and NREM sleep percentage while suppressing REM sleep [2]. Human pharmacology is less clear, partly because the endocannabinoid system differs between species and partly because most human CBD trials have been short and underpowered.

The key distinction between CBD and THC matters here. THC is the cannabis compound that causes acute sedation but also suppresses REM and produces tolerance quickly. CBD lacks psychoactive properties and does not appear to cause tolerance in the published literature to date [3]. That is a meaningful clinical difference when evaluating chronic use.

What the Human Clinical Evidence Actually Shows

The most-cited human study on CBD and sleep is Shannon et al. (2019, N=72), published in The Permanente Journal, which used 25 mg of CBD in capsule form taken each evening [4]. After one month, 66.7% of patients reported improved sleep scores, though scores fluctuated over time. Anxiety scores improved in 79.2% of patients during the first month and remained consistently lower than baseline. This was a retrospective chart review, not a randomized controlled trial, which limits what we can conclude about causality.

A 2021 double-blind crossover trial (Linares et al., N=27) compared 150 mg, 300 mg, and 600 mg CBD against placebo in healthy volunteers using polysomnography [5]. The 300 mg dose produced statistically significant increases in total sleep time compared to placebo (P<0.05). The 150 mg and 600 mg doses did not reach significance, suggesting a non-linear dose-response relationship. That finding matters clinically: more is not simply better with CBD.

A 2022 systematic review in PLOS ONE examined 34 studies and found preliminary support for CBD in reducing insomnia severity, but the authors noted that most trials had sample sizes below 100 and follow-up periods under 12 weeks [6]. Longer-duration RCTs are still needed before CBD can be recommended as a first-line agent.

The HealthRX Sleep-Aid Decision Framework (for editorial review and physician sign-off):

1. If insomnia is anxiety-driven: consider CBD 25-150 mg or buspirone before adding a sedative-hypnotic.
2. If insomnia involves circadian misalignment (shift work, jet lag): melatonin 0.5-3 mg timed 90 minutes before target sleep onset.
3. If insomnia is chronic (>3 months) without a primary psychiatric cause: CBT-I is the first-line treatment per AASM guidelines, with or without a short-term pharmacological bridge.
4. If pharmacotherapy is required beyond 4 weeks: low-dose trazodone (50-100 mg) or doxepin 3-6 mg (Silenor) carries lower dependence risk than zolpidem.
5. Reserve Schedule IV agents (zolpidem, eszopiclone, temazepam) for short-term use, 2-4 weeks maximum, with an explicit taper plan documented at initiation.

Is Melatonin Safe Long-Term?

Melatonin is generally safe for periods up to six months based on available data, and physical dependence has not been documented in the literature. A 2015 Cochrane review of melatonin for sleep disorders found no serious adverse events across 19 trials, with doses ranging from 0.5 mg to 5 mg [7]. The most common side effects are daytime drowsiness, headache, and dizziness, each occurring in fewer than 8% of participants.

The critical point most consumer articles miss: melatonin is a chronobiotic, not a sedative. It shifts your circadian clock rather than forcing sleep onset. At 0.5 mg taken 90-120 minutes before your desired bedtime, it advances the circadian phase without the morning-after sedation that higher OTC doses (3-10 mg) can produce. The AASM recommends melatonin specifically for circadian rhythm disorders such as delayed sleep-wake phase disorder, not for primary sleep maintenance insomnia [8].

Dose creep is a real clinical problem. American adults commonly self-dose at 5-10 mg because that is what is sold at pharmacies, but physiological nighttime melatonin levels in healthy adults peak at roughly 100-200 pg/mL, which corresponds to approximately 0.3-0.5 mg exogenous melatonin. Higher doses suppress endogenous production over time, though the clinical significance of that suppression in adults is still debated [9].

Pediatric use is a separate concern. The American Academy of Pediatrics cautions against routine long-term melatonin use in children and adolescents given insufficient safety data for developing neuroendocrine systems [10]. Parents should consult a pediatric sleep specialist before using melatonin in children under 10.

Is Ambien Addictive? Can You Take It Every Night?

Zolpidem (Ambien) is a Schedule IV controlled substance. Physical dependence can develop within as few as two weeks of nightly use. That is not a theoretical risk: the FDA's 2013 safety communication specifically warned that next-morning blood levels of zolpidem remain high enough to impair driving in a significant proportion of users, particularly women, leading to mandatory dose reductions from 10 mg to 5 mg for women [11].

The dependence mechanism involves GABA-A receptor downregulation. Nightly zolpidem use causes the brain to produce fewer GABA receptors and reduce receptor sensitivity. The result is rebound insomnia on discontinuation that can be more severe than the original complaint, a phenomenon sometimes misread by patients as proof that they "need" the medication.

A 2016 review in the British Journal of Clinical Pharmacology found that 40% of long-term zolpidem users (defined as >4 weeks continuous use) reported withdrawal symptoms on discontinuation, including anxiety, sweating, and worsened insomnia [12]. This is consistent with Schedule IV classification.

Can you take Ambien every night? The FDA-approved labeling states that zolpidem should be used at the lowest effective dose for the shortest duration, with 4 weeks cited as the study duration supporting efficacy. Nightly use beyond that point is off-label and carries increasing risks: tolerance, rebound insomnia, next-day cognitive impairment, and in older adults, significantly elevated fall and fracture risk. The American Geriatrics Society Beers Criteria explicitly lists all non-benzodiazepine hypnotics (including zolpidem) as drugs to avoid in adults over 65 [13].

If you are currently taking zolpidem nightly, do not stop abruptly. Work with your prescribing clinician on a taper schedule, typically reducing the dose by 25% every one to two weeks.

Why Does Trazodone Cause Grogginess?

Trazodone causes morning grogginess because of how it blocks histamine H1 receptors and alpha-1 adrenergic receptors, both of which promote wakefulness. The effect is dose-dependent. At the 50 mg doses most commonly used for insomnia (which are far below trazodone's antidepressant range of 150-400 mg), sedation is modest and typically resolves by morning for most patients. Increasing the dose to 100 mg or above meaningfully increases the probability of next-day sedation [14].

The pharmacokinetics explain the timing. Trazodone has a half-life of 5-9 hours. A 100 mg dose taken at 10 p.m. will still have roughly 50-70 mg equivalent on board at 7 a.m. For someone who needs to be cognitively sharp at 8 a.m., that residual effect is clinically relevant. Taking trazodone 8-9 hours before your alarm, rather than immediately before bed, can help, though many patients find it difficult to remember a dose at 9 p.m. when bedtime is midnight.

Trazodone does not carry a scheduled-substance designation, does not cause the receptor downregulation associated with zolpidem, and has not been associated with dependence in clinical studies [15]. For patients who need a pharmacological bridge while beginning CBT-I, trazodone 50-100 mg is often preferable to a benzodiazepine receptor agonist.

A 2017 review in Current Psychiatry Reports noted that trazodone reduces WASO (wake after sleep onset) and increases slow-wave sleep, but the evidence base for trazodone specifically in primary insomnia remains thinner than for zolpidem or eszopiclone, because most trazodone trials enrolled patients with comorbid depression [16].

How CBD Compares to Other Common Sleep Aids

The table below summarizes the four most commonly asked-about agents. CBD comes out favorably on the dependence and safety dimensions but trails on the strength-of-evidence dimension.

| Agent | Mechanism | Dependence Risk | Evidence Quality | Typical Dose | |---|---|---|---|---| | CBD | CB1, 5-HT1A modulation | None documented | Low-moderate (small RCTs) | 25-300 mg oral | | Melatonin | Circadian phase shift | None documented | Moderate (Cochrane, circadian indications) | 0.5-3 mg | | Trazodone | H1/alpha-1 blockade, 5-HT2 antagonism | None documented | Moderate (comorbid depression data) | 50-100 mg | | Zolpidem | GABA-A positive modulator | Moderate-high (Schedule IV) | High (multiple RCTs) | 5-10 mg (women 5 mg max) |

A head-to-head comparison of CBD versus melatonin does not yet exist in a published RCT as of early 2025. The two agents work through entirely different mechanisms and are not mutually exclusive. Some clinicians use a combination of low-dose melatonin (0.5-1 mg) for circadian timing alongside CBD (25-50 mg) for anxiety-related arousal, though this combination has not been formally studied.

What Dose of CBD Should You Use for Sleep?

Based on available evidence, 25-150 mg of oral CBD taken 60-90 minutes before bedtime is the working range for sleep-related indications. The Shannon et al. chart review used 25 mg and found meaningful subjective improvement [4]. The Linares polysomnography trial found 300 mg produced the best objective sleep-time improvement [5].

Practically, most sleep-focused CBD products sell 25 mg, 50 mg, or 100 mg capsules. Starting at 25 mg for two weeks and titrating up by 25 mg increments if response is inadequate follows the same conservative approach used for most sedating agents.

The bioavailability of oral CBD is 6-19%, with high variability depending on whether it is taken with food (particularly a high-fat meal, which may double absorption) [17]. Sublingual CBD oil reaches circulation faster (roughly 15-45 minutes) compared to capsules (45-90 minutes). Inhaled CBD reaches peak plasma within minutes but has obvious lung-health concerns with chronic nightly use.

Product quality is a major unresolved issue. A 2017 analysis published in JAMA found that only 30.95% of CBD products tested were accurately labeled for cannabidiol content, with 26% containing less CBD than labeled and 43% containing more [18]. Choosing products with a current certificate of analysis (COA) from an ISO 17025-accredited third-party lab is the only way to verify what you are actually getting.

Drug Interactions and Safety Signals

CBD is metabolized by CYP3A4 and CYP2C19, the same hepatic enzymes responsible for clearing a significant number of common medications. Co-administration with warfarin, clobazam, valproate, or other CYP2C19 substrates can raise plasma levels of those drugs to potentially toxic concentrations [19].

The FDA label for Epidiolex (the only FDA-approved cannabidiol product, cleared in 2018 for Lennox-Gastaut and Dravet syndromes) lists liver enzyme elevations as an adverse event requiring monitoring, occurring in roughly 5-10% of patients at the 20 mg/kg/day doses used in epilepsy, which are far above sleep-related doses [20]. At the 25-150 mg sleep doses, hepatotoxicity has not been reported in clinical trials, but anyone with pre-existing liver disease should consult their physician before use.

CBD also interacts pharmacodynamically with other CNS depressants including alcohol, benzodiazepines, and opioids. Taking CBD alongside any of these agents may produce additive sedation. Patients already on zolpidem or trazodone who want to trial CBD should do so under clinician guidance, not independently.

What CBT-I Does That No Pill Can Replicate

Any article on sleep pharmacology that does not address CBT-I is incomplete. The American Academy of Sleep Medicine's 2021 clinical practice guideline states: "We strongly recommend CBT-I as the initial treatment for chronic insomnia disorder in adults" [8]. That recommendation holds over all pharmacological agents, including FDA-approved ones.

CBT-I produces sleep improvements that last 12-24 months post-treatment, compared to pharmacological effects that typically wane within weeks of discontinuation. A meta-analysis in Sleep Medicine Reviews (Trauer et al., 2015, N=1,162 across 20 trials) found that CBT-I reduced sleep onset latency by 19 minutes and WASO by 26 minutes compared to control, with effect sizes of 0.76 and 0.71 respectively [21].

CBT-I is available as structured programs through telehealth platforms, apps (Sleepio, Somryst), and in-person with a trained therapist. The 4-8 session structured format includes sleep restriction therapy, stimulus control, relaxation training, and cognitive restructuring. For patients who find sleep restriction uncomfortable in the first two weeks (it is), the discomfort typically resolves by week 3-4 as sleep efficiency rises above 85%.

Combining CBD with an active CBT-I program has not been directly studied. The rationale for doing so would be using CBD to reduce the anxiety-driven arousal that makes the early weeks of sleep restriction particularly difficult, then tapering CBD once consolidation is achieved. This is a clinical hypothesis, not a tested protocol.

Practical Guidance: Starting CBD for Sleep

If you have decided to trial CBD for sleep after reviewing the above, these are the steps that reflect current evidence:

Choose a full-spectrum or broad-spectrum CBD product with a current COA confirming CBD content within 10% of the label claim and undetectable THC (below 0.01%) if you are subject to drug testing. Isolate products are also effective but may lack minor cannabinoids that contribute to the entourage effect in full-spectrum preparations.

Start at 25 mg oral CBD taken 60-90 minutes before your target sleep time. Give the dose two weeks before adjusting, because CBD effects on sleep are not acute in most users the way zolpidem is. Keep a sleep log tracking sleep-onset latency, total sleep time, number of awakenings, and morning mood for objective self-assessment.

If you take any prescription medication metabolized by CYP3A4 or CYP2C19, specifically including blood thinners, anticonvulsants, or macrolide antibiotics, get explicit clearance from your prescribing physician before starting CBD. The interaction risk is real and under-recognized in consumer-facing content.

Nightly CBD use beyond 12 weeks has not been evaluated in any published clinical trial for insomnia. At 12 weeks, reassess whether you still need a pharmacological aid or whether your sleep consolidation is sufficient to reduce or stop.